MarketVIEW: Norovirus vaccines (CAT No: VAMV015)VacZine AnalyticsJuly 1, 2010 35 Pages - SKU: VZAN2769709 |
| Noroviruses (NVs) called “Norwalk-like viruses” are transmitted from human-to-human and are one of the most highly infectious viruses known. In the community, NVs most commonly cause a self-limiting mild disease of short duration with gastrointestinal symptoms usually resolving after 1 to 3 days. However, it is the sheer volume of infections and burden on healthcare systems that presents the biggest challenge. In the US, NV infections may account for 235,000 clinic visits, 91,000 emergency room visits and 23.000 hospitalizations among children <5 years of age. There is also evidence that norovirus epidemics are growing in magnitude, severity and in the elderly population, may even be causing fatalities. NV outbreaks are also a well known issue for military installations and commercial cruise ship liners.
A key question for vaccine manufacturers is whether norovirus will be the next rotavirus, and so a commercial opportunity for future development. Presently there is only one known norovirus active program being developed by Montana-based Ligocyte who acquired intellectual property (IP) from Baylor College of Medicine and are supported by the U.S. Army Medical Research and Material Command. This MarketVIEW product is a comprehensive MS Excel-based model + summary presentation which forecasts the potential commercial value of Norovirus across major Western and emerging markets to 2030. The model contains value ($ m) and volume (mio doses) predictions along with launch timeframe, TPP, pricing and penetration estimates. LO/BASE/HI forecast scenarios are included based upon the level of populations targeted by a potential vaccine. Please note: this is delivered as a Zip file. |
Related Markets
Infectious Diseases Reports
- Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential
- Global Infectious Disease Treatment Market 2011-2014
- World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)
- Global Infectious Disease Market Outlook: Facilities, Test Volume, and Sales Forecasts by Country
- Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast
